Keyword search (4,163 papers available)

"nap" Keyword-tagged Publications:

Title Authors PubMed ID
1 Habitual napping in older adults is accompanied by altered heat-loss rhythms across the circadian cycle and reduced coupling between pre-sleep thermoregulatory dynamics and sleep initiation Dourte M; Hammad G; de Haan S; Deantoni M; Reyt M; Baillet M; Lesoinne A; Muto V; Collette F; Vandewalle G; Peigneux P; Cajochen C; Schmidt C; 41797810
PSYCHOLOGY
2 Dopamine inhibits excitatory synaptic responses in layer I of the rat parasubiculum Carter F; Hobishi H; Chapman CA; 40818632
PSYCHOLOGY
3 Syngap1 regulates the synaptic drive and membrane excitability of Parvalbumin-positive interneurons in mouse auditory cortex Francavilla R; Chattopadhyaya B; Damo Kamda JL; Jadhav V; Kourrich S; Michaud JL; Di Cristo G; 40810392
CSBN
4 Progesterone and allopregnanolone facilitate excitatory synaptic transmission in the infralimbic cortex via activation of membrane progesterone receptors Rahaei N; Buynack LM; Kires L; Movasseghi Y; Chapman CA; 39722289
PSYCHOLOGY
5 The effects of acute exercise and a nap on heart rate variability and memory in young sedentary adults Mograss M; Frimpong E; Vilcourt F; Chouchou F; Zvionow T; Dang-Vu TT; 37855092
PERFORM
6 Inhibiting amyloid beta (1-42) peptide-induced mitochondrial dysfunction prevents the degradation of synaptic proteins in the entorhinal cortex Olajide OJ; La Rue C; Bergdahl A; Chapman CA; 36275011
HKAP
7 The effects of napping on night-time sleep in healthy young adults Melodee Mograss 35253300
PERFORM
8 G protein-coupled estrogen receptor-1 enhances excitatory synaptic responses in the entorhinal cortex Batallán Burrowes AA; Sundarakrishnan A; Bouhour C; Chapman CA; 34399010
PSYCHOLOGY
9 Are the Allergic Reactions of COVID-19 Vaccines Caused by mRNA Constructs or Nanocarriers? Immunological Insights Selvaraj G; Kaliamurthi S; Peslherbe GH; Wei DQ; 34021862
CHEMBIOCHEM
10 Neurobehavioral, neurochemical and synaptic plasticity perturbations during postnatal life of rats exposed to chloroquine in-utero Olajide OJ; Alliy ZO; Ojo DO; Osinubi OO; Bello SO; Ibrahim FE; Adukwu FO; Abikoye TO; Gbadamosi IT; Mutholib NY; Bamisi O; Ajiboye OJ; Okesina AA; Alli-Oluwafuyi A; Oyewole AL; Nafiu AB; Akinola O; 33845156
PSYCHOLOGY
11 Atrx Deletion in Neurons Leads to Sexually Dimorphic Dysregulation of miR-137 and Spatial Learning and Memory Deficits. Tamming RJ, Dumeaux V, Jiang Y, Shafiq S, Langlois L, Ellegood J, Qiu LR, Lerch JP, Bérubé NG 32610139
PERFORM
12 Exercising before a nap benefits memory better than napping or exercising alone. Mograss M, Crosetta M, Abi-Jaoude J, Frolova E, Robertson E, Pepin V, Dang-Vu TT 32236442
PERFORM
13 Heterosynaptic modulation of evoked synaptic potentials in layer II of the entorhinal cortex by activation of the parasubiculum. Sparks DW, Chapman CA 27146979
PSYCHOLOGY

 

Title:Are the Allergic Reactions of COVID-19 Vaccines Caused by mRNA Constructs or Nanocarriers? Immunological Insights
Authors:Selvaraj GKaliamurthi SPeslherbe GHWei DQ
Link:https://pubmed.ncbi.nlm.nih.gov/34021862/
DOI:10.1007/s12539-021-00438-3
Publication:Interdisciplinary sciences, computational life sciences
Keywords:AnaphylaxisAntibodyBNT162b2COVID-19IgEMRNA vaccineMRNA-1273PEGSARS-CoV-2
PMID:34021862 Category: Date Added:2021-05-22
Dept Affiliation: CHEMBIOCHEM
1 Centre for Research in Molecular Modeling, Department of Chemistry and Biochemistry, Concordia University, 7141 Sherbrooke Street W, Montreal, QC, H4B1R6, Canada. gurudeeban.selvaraj@concordia.ca.
2 Centre for Research in Molecular Modeling, Department of Chemistry and Biochemistry, Concordia University, 7141 Sherbrooke Street W, Montreal, QC, H4B1R6, Canada.
3 The State Key Laboratory of Microbial Metabolism, College of Life Sciences and Biotechnology, Shanghai Jiao Tong University, No. 800 Dongchuan Road, Minhang, Shanghai, 200240, China. dqwei@sjtu.edu.cn.
4 IASIA (International Association of Scientists in the Interdisciplinary Areas), 125 Boul. de Bromont, Quebec, QC, J2L 2K7, Canada. dqwei@sjtu.edu.cn.

Description:

The Food and Drug Administration (FDA) has recently authorized the two messenger RNA (mRNA) vaccines BNT162b2 and mRNA-1273 for emergency use against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing the COVID-19 coronavirus disease. BNT162b2 and mRNA-1273 vaccines were developed by Pfizer-BioNTech and Moderna, respectively, in 2020. The United Kingdom, Bahrain, Canada, Mexico, United States, Singapore, Oman, Saudi Arabia, Kuwait, and European Union began their vaccination programs with the BNT162b2 vaccine, while the United States and Canada also started the mRNA-1273 vaccination program in mid December 2020. On 28th December 2020, studies reported severe allergic reactions in people who received the BNT162b2, and few people who received the mRNA-1273 vaccine. Authors of the letter thus attempt to explore possible causes of anaphylaxis following COVID-19 vaccination.





BookR developed by Sriram Narayanan
for the Concordia University School of Health
Copyright © 2011-2026
Cookie settings
Concordia University